These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33271167)

  • 1. Predicting drug-induced liver injury from anti-tuberculous medications by early monitoring of liver tests.
    Patterson B; Abbara A; Collin S; Henderson M; Shehata M; Gorgui-Naguib H; Lynn W; Kon OM; John L
    J Infect; 2021 Feb; 82(2):240-244. PubMed ID: 33271167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK.
    Abbara A; Chitty S; Roe JK; Ghani R; Collin SM; Ritchie A; Kon OM; Dzvova J; Davidson H; Edwards TE; Hateley C; Routledge M; Buckley J; Davidson RN; John L
    BMC Infect Dis; 2017 Mar; 17(1):231. PubMed ID: 28340562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel risk factors and early detection of anti tubercular treatment induced liver injury-Looking beyond American Thoracic Society Guidelines.
    Latief M; Dar WR; Sofi N; Dar IA; Kasana B; Hussain M; Arshad F; Shah BA; Koul PA
    Indian J Tuberc; 2017 Jan; 64(1):26-32. PubMed ID: 28166913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting antitubercular drug-induced liver injury and its outcome and introducing a novel scoring system.
    Raj Mani SS; Iyyadurai R; Mishra AK; Manjunath K; Prasad J; Lakshmanan J; Yadav B; Reginald A; Jasmine S; Hansdak SG; Zachariah A
    Int J Mycobacteriol; 2021; 10(2):116-121. PubMed ID: 34558461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do genetic polymorphisms of B-cell CLL/lymphoma 2 confer susceptibility to anti-tuberculous therapy-associated drug-induced liver injury?
    Lyu M; Jiao L; Zhou J; Li H; Meng Z; Xie W; Ren J; Bian Q; Ying B
    Int J Infect Dis; 2020 Feb; 91():223-231. PubMed ID: 31838216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of TB/HIV co-infected patients presenting with antituberculosis drug-induced liver injury.
    Naidoo S; Evans D; Jong E; Mellet K; Berhanu R
    S Afr Med J; 2015 Apr; 105(5):393-6. PubMed ID: 26242667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malnutrition as an important risk factor for drug-induced liver injury in patients on anti-tubercular therapy: an experience from a tertiary care center in South India.
    Ali N; Gupta N; Saravu K
    Drug Discov Ther; 2020; 14(3):135-138. PubMed ID: 32669522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Hepatotoxicity From Antituberculosis Therapy: A Five-Year Experience From South India.
    Saha A; Shanthi F X M; Winston A B; Das S; Kumar A; Michael JS; Balamugesh T
    J Prim Care Community Health; 2016 Jul; 7(3):171-4. PubMed ID: 27056794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of statins on the risk of anti-tuberculosis drug-induced liver injury among patients with active tuberculosis: A cohort study.
    Huang CK; Huang JY; Chang CH; Tsai SJ; Shu CC; Wang HC; Chien KL
    J Microbiol Immunol Infect; 2024 Jun; 57(3):498-508. PubMed ID: 38632021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of hepatitis B infection in anti-tuberculosis drug-induced liver injury: a meta-analysis of cohort studies.
    Zheng J; Guo MH; Peng HW; Cai XL; Wu YL; Peng XE
    Epidemiol Infect; 2020 Nov; 148():e290. PubMed ID: 33222713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An official ATS statement: hepatotoxicity of antituberculosis therapy.
    Saukkonen JJ; Cohn DL; Jasmer RM; Schenker S; Jereb JA; Nolan CM; Peloquin CA; Gordin FM; Nunes D; Strader DB; Bernardo J; Venkataramanan R; Sterling TR;
    Am J Respir Crit Care Med; 2006 Oct; 174(8):935-52. PubMed ID: 17021358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis.
    Park WB; Kim W; Lee KL; Yim JJ; Kim M; Jung YJ; Kim NJ; Kim DH; Kim YJ; Yoon JH; Oh MD; Lee HS
    J Infect; 2010 Oct; 61(4):323-9. PubMed ID: 20670648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of drug-induced liver injury in chronic hepatitis B and tuberculosis co-infection: A systematic review and meta-analysis.
    Chou C; Veracruz N; Chitnis AS; Wong RJ
    J Viral Hepat; 2022 Dec; 29(12):1107-1114. PubMed ID: 36138556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAT2 variants are associated with drug-induced liver injury caused by anti-tuberculosis drugs in Indonesian patients with tuberculosis.
    Yuliwulandari R; Susilowati RW; Wicaksono BD; Viyati K; Prayuni K; Razari I; Kristin E; Syafrizal ; Subagyo ; Sri Diana E; Setiawati S; Ariyani A; Mahasirimongkol S; Yanai H; Mushiroda T; Tokunaga K
    J Hum Genet; 2016 Jun; 61(6):533-7. PubMed ID: 26911349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-Induced Liver Injury from Anti-Tuberculosis Treatment: A Retrospective Cohort Study.
    Zhao H; Wang Y; Zhang T; Wang Q; Xie W
    Med Sci Monit; 2020 Mar; 26():e920350. PubMed ID: 32145061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible role for acetylcysteine as a treatment for acute liver failure secondary to antitubercular medication use.
    Fox AN; Nation BE; Autry MT; Johnson PN
    Am J Health Syst Pharm; 2020 Sep; 77(18):1482-1487. PubMed ID: 32885827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the Prophylactic Use of Hepatoprotectants Necessary in Anti-Tuberculosis Treatment?
    Xu L; Zhang F; Xu C; Liu KG; Wu W; Tian YX
    Chemotherapy; 2017; 62(5):269-278. PubMed ID: 28490012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury.
    Kim WS; Lee SS; Lee CM; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ; Hong JW; You HS; Cho HC
    BMC Infect Dis; 2016 Feb; 16():50. PubMed ID: 26833347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients.
    Wattanapokayakit S; Mushiroda T; Yanai H; Wichukchinda N; Chuchottawon C; Nedsuwan S; Rojanawiwat A; Denjanta S; Kantima T; Wongyai J; Suwankesawong W; Rungapiromnan W; Kidkeukarun R; Bamrungram W; Chaiwong A; Suvichapanich S; Mahasirimongkol S; Tokunaga K
    Int J Tuberc Lung Dis; 2016 Oct; 20(10):1364-1369. PubMed ID: 27725049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine metabolomics and microbiome analyses reveal the mechanism of anti-tuberculosis drug-induced liver injury, as assessed for causality using the updated RUCAM: A prospective study.
    Wang MG; Wu SQ; Zhang MM; He JQ
    Front Immunol; 2022; 13():1002126. PubMed ID: 36483548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.